237 results
8-K
EX-99.3
WINT
Windtree Therapeutics Inc
4 Nov 04
Entry into a Material Definitive Agreement
12:00am
FACILITY
WITH GE HEALTHCARE FINANCIAL SERVICES TO APPROXIMATELY $9 MILLION
DOYLESTOWN, PA --NOVEMBER 2, 2004 -- DISCOVERY LABORATORIES, INC … . (NASDAQ: DSCO)
today announced that available funds under its existing capital lease financing
facility with GE Healthcare Financial Services have
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
24 May 07
Entry into a Material Definitive Agreement
12:00am
’ Executive Vice President and Chief Financial Officer, commented, “We are pleased to establish a relationship with Merrill Lynch Capital Healthcare Finance … , equipment finance, healthcare finance and real estate finance. The Healthcare Finance Group of Merrill Lynch Capital provides senior financing
424B3
WINT
Windtree Therapeutics Inc
21 Mar 06
Prospectus supplement
12:00am
A Warrants have assigned their warrants: (i) Castle Creek Healthcare Partners LLC has assigned its Class A Warrant to purchase 20,000 shares of our common …
Percentage to be Beneficially Owned After this Offering
Castle Creek Healthcare Partners LLC
CC LifeScience, Ltd.
CC LifeScience Market Neutral Fund, Ltd.
D3
8-K
EX-99.1
WINT
Windtree Therapeutics Inc
3 Aug 09
Discovery Labs Provides Second Quarter 2009 Financial Results and Business Strategy Update
12:00am
year. However today, fewer than 200,000 infants receive surfactant therapy (with animal-derived surfactants) because healthcare practitioners try … to a liquid immediately prior to administration. This formulation is intended to improve product flexibility and ease of use for healthcare practitioners
PRER14C
6bh7aye
17 Jul 19
Preliminary revised information
5:29pm
8-K
EX-99.1
4v1 z3c2f
1 Jun 11
Other Events
12:00am
DEF 14C
gh1qd8q dy49set332x
18 Jul 19
Information statement
4:49pm
8-K
EX-99.1
9vx085uq7 z13x3cx
13 Feb 13
Discovery Labs Receives $30 Million Funding Commitment from Deerfield Management
12:00am
8-K
EX-99.1
z4nu6tcq
29 Jul 11
Other Events
12:00am
8-K
EX-99.2
62ppvt1ot6bvz r59
4 Nov 04
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
db2oimw3znmpxlp07
2 Jun 08
Entry into a Material Definitive Agreement
12:00am
8-K
zba9mz4lilmc
25 Aug 10
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
gj551i6 4i5
28 Sep 11
Other Events
12:00am
424B4
84hu31dcsm szv8l3
20 Apr 23
Prospectus supplement with pricing info
6:03pm
PRE 14C
0c00hfikgxv7l5 bg
24 Jun 19
Preliminary information
4:25pm